Gene · 5345
Papers4,537
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
461 to 480 of 4,537
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| SHP-2-induced M2 polarization of tumor associated macrophages via IL-4 regulate colorectal cancer progression. | Front Oncol | 2023 | 36776333 | PubTator, text mining | PubMed |
| Proteomic Mediators of Overall Cardiovascular Health on All-Cause Mortality. | Nutrients | 2023 | 36771486 | PubTator, text mining | PubMed |
| The Role of the Plasminogen/Plasmin System in Inflammation of the Oral Cavity. | Cells | 2023 | 36766787 | PubTator, text mining | PubMed |
| Point-of-care diagnosis and monitoring of fibrinolysis resistance in the critically ill: results from a feasibility study. | Crit Care | 2023 | 36765421 | PubTator, text mining | PubMed |
| PLCL/PCL Dressings with Platelet Lysate and Growth Factors Embedded in Fibrin for Chronic Wound Regeneration. | Int J Nanomedicine | 2023 | 36760757 | PubTator, text mining | PubMed |
| The brain reacting to COVID-19: analysis of the cerebrospinal fluid proteome, RNA and inflammation. | J Neuroinflammation | 2023 | 36759861 | PubTator, text mining | PubMed |
| Inhibition of MMPs supports amoeboid angiogenesis hampering VEGF-targeted therapies via MLC and ERK 1/2 signaling. | J Transl Med | 2023 | 36759828 | PubTator, text mining | PubMed |
| Assays to quantify fibrinolysis: strengths and limitations. Communication from the International Society on Thrombosis and Haemostasis Scientific and Standardization Committee on fibrinolysis. | J Thromb Haemost | 2023 | 36759279 | PubTator, text mining | PubMed |
| Hepatocyte-derived Microparticles as Novel Biomarkers for the Diagnosis of Deep Venous Thrombosis in Trauma Patients. | Clin Appl Thromb Hemost | 2023 | 36749023 | PubTator, text mining | PubMed |
| Mechanistic basis of staphylococcal interspecies competition for skin colonization. | bioRxiv | 2023 | 36747832 | PubTator, text mining | PubMed |
| Comprehensive structural characterization of the human AAA+ disaggregase CLPB in the apo- and substrate-bound states reveals a unique mode of action driven by oligomerization. | PLoS Biol | 2023 | 36745679 | PubTator, text mining | PubMed |
| Relationship between Claims-Based Frailty Index and Eye Care Utilization among Medicare Beneficiaries with Glaucoma. | Ophthalmology | 2023 | 36731798 | PubTator, text mining | PubMed |
D-dimer Release From Livers During Ex Situ Normothermic Perfusion and After In Situ Normothermic Regional Perfusion: Evidence for Occult Fibrin Burden Associated With Adverse Transplant Outcomes and Cholangiopathy. | Transplantation | 2023 | 36728501 | PubTator, text mining | PubMed |
| Plasma from patients with pulmonary embolism show aggregates that reduce after anticoagulation. | Commun Med (Lond) | 2023 | 36709220 | PubTator, text mining | PubMed |
| Staphylococcal Periscope proteins Aap, SasG, and Pls project noncanonical legume-like lectin adhesin domains from the bacterial surface. | J Biol Chem | 2023 | 36702253 | PubTator, text mining | PubMed |
| Characterization of the humanized FRG mouse model and development of an AAV-LK03 variant with improved liver lobular biodistribution. | Mol Ther Methods Clin Dev | 2023 | 36700121 | PubTator, text mining | PubMed |
| The usefulness of tranexamic acid for bleeding symptoms of chronic consumptive coagulopathy complicated by aortic disease: a single-institute, retrospective study of 14 patients. | Thromb J | 2023 | 36698142 | PubTator, text mining | PubMed |
| Analysis of thrombogenicity under flow reveals new insights into the prothrombotic state of patients with post-COVID syndrome. | J Thromb Haemost | 2023 | 36695401 | PubTator, text mining | PubMed |
| Estradiol provokes hypercoagulability and affects fibrin biology: A mechanistic exploration of sex dimorphisms in coagulation. | J Trauma Acute Care Surg | 2023 | 36694329 | PubTator, text mining | PubMed |
| Comparative susceptibility of SARS-CoV-2, SARS-CoV, and MERS-CoV across mammals. | ISME J | 2023 | 36690780 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/5345/papers?page=24